About this episode
GU Cast chats to Dr Petros Grivas, GU Medical Oncologist at the University of Washington in Seattle, about the JAVELIN 100 trial which featured in the plenary session at ASCO20 recently. Petros is senior author on this practice-changing study of "switch maintenance" in metastatic bladder cancer, and he joins us today to explain some of the finer details of the study. With audio cameos from Tom Powles, Betsy Plimack, and Vinay Prasad (yikes!).
Declan and Renu were also delighted to have Associate Professor Andrew Weickhardt join them in studio today. Andrew is a GU Medical Oncologist at the Olivia-Newton John Cancer Centre and Austin Hospital in Melbourne, where he leads the GU Oncology trials team.
Get every episode summarized
Each time GU Cast | Urology Podcast publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from GU Cast | Urology Podcast
Is Copper the new Gold??! Co-PSMA trial in European Urology
GU Cast | Urology Podcast
EAU Prostate Cancer Guideline Update
GU Cast | Urology Podcast
Journal club #7 | proPSMA and Penile Fractures(!)
GU Cast | Urology Podcast
ASPIRE-ing to answer the Triplet question! With Rana McKay and Deepak Kilari
GU Cast | Urology Podcast